Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based therapies, has unveiled plans to expand its state-of-the-art, purpose-built facility in Hopkinton, MA. The expansion is driven by the significant and growing demand for cell therapy process development and manufacturing.   Seven ISO 7 cGMP suites will be added to the existing facility with capabilities for both autologous and allogeneic production bringing the total number of clinical and commerc...